Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

The 30+ industry pushing speakers 

If you're interested in getting involved get in touch at: Jmackintosh@eyeforpharma.com   


Adrienne Lovink

Adrienne Lovink

Partner, Consulting, DRG

Read more

More information coming soon...

Amanda Bruno

Amanda Bruno

Head, Value, Evidence and Access, Oncology, GSK

Read more

More information coming soon...

Anjan Chatterjee

Anjan Chatterjee

VP, Global Head, Real World Evidence - COE, Epidemiology and Big Data, Boehringer Ingelheim

Read more

More information coming soon...

April Naegeli

April Naegeli

Senior Research Scientist, Eli Lilly

Read more

More information coming soon...

Brad Patrick

Brad Patrick

Division Counsel, Abbvie

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Bryan Hill

Bryan Hill

Medical Science Director, Mitsubishi 

Read more

More information coming soon...

Camie Britton

Camie Britton

Senior Director, PAREXEL

Read more

More information coming soon...

Christopher Boone

Christopher Boone

VP, Real World Data and Analytics, Pfizer

Read more

More information coming soon...

Dan Leonard

Dan Leonard

President, National Pharmaceutical Council

Read more

More information coming soon...

David Hartenbaum

David Hartenbaum

Executive Director, Account Management, Merck

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Denise Globe

Denise Globe

VP, Head Global Real World Evidence Center of Excellence, Vertex Pharmaceuticals

Read more

More information coming soon...

Denise Meade

Denise Meade

Director of Product Management, IBM Watson Health

Read more

More information coming soon...

Diana Stefani-Hunyady

Diana Stefani-Hunyady

Global Senior Director, IL-23 Medical Affairs Launch Lead, Eli Lilly

Read more

More information coming soon...

Eric Wittbrodt

Eric Wittbrodt

Director, Epidemiology, AstraZeneca 

Read more

More information coming soon...

Gergana Zlateva, Ph.D.

Gergana Zlateva, Ph.D.

Vice President, Payer Insights and Access, Pfizer Oncology

Read more

Gergana Zlateva is a Vice President, Oncology Global Lead for Payer Insights & Access (PI&A) in Global Health & Value. Gergana’ s team provides both region-specific and global support in the development and implementation of market access, pricing, reimbursement, and health technology assessment strategies for Pfizer’s oncology portfolio. Prior to this role, Gergana was the PI&A Cluster Lead for North America, and managed a team of colleagues supporting Pfizer’s portfolio and its 3 business: GIP, GEP, and VOC.  During her 13 year tenure with Pfizer, Gergana has held various positions of increasing responsibility covering health economics, outcomes research, and pricing and reimbursement activities across several therapy areas and different geographies. Gergana has led multiple cross-functional teams in preparation of pricing and reimbursement negotiations in developed markets and has presented on behalf of PFE to public and private payer organizations in the EU and US. Prior to joining Pfizer in 2003, Gergana worked for 5 years on public health, civil society, and business development programs with several United Nations agencies. Gergana holds a PhD in Economics from Fordham University, NY and a BA and MPA from Southern Illinois University, IL. Gergana’s CV includes more than 60 peer-reviewed manuscripts, as well as a number of poster and podium presentations.

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Harry Vargo

Harry Vargo

Director, Value Based Contracting and Manufacturer Trade Relations, Aetna

Read more

More information coming soon...

John Bardi

John Bardi

VP, Public Affairs and Digital Medicine, Business Development, Otsuka

Read more

More information coming soon...

Khair ElZarrad

Khair ElZarrad

Deputy Director, Office of Medical Policy, FDA

Read more

More information coming soon...

Martin Marciniak

Martin Marciniak

Vice-President, U.S. Medical Affairs, Customer Engagement, Value, Evidence and Outcomes, GSK

Read more

More information coming soon...

Matt Portch

Matt Portch

Vice President, Managed Markets, Sunovion Pharmaceutical

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Michael Labson

Michael Labson

Partner, Covington

Read more

More information coming soon...

Michael Mittelman

Michael Mittelman

Executive Director, American Living Organ Donor Fund

Read more

More information coming soon...

Michael Thompson

Michael Thompson

President & CEO, National Alliance of Healthcare Purchaser Coalitions

Read more

More information coming soon...

Michael Ujhelyi

Michael Ujhelyi

Senior Medical Director, BTG

Read more

More information coming soon...

Patrick Loerch

Patrick Loerch

Senior Director, Data Sciences (Information, Knowledge Utilization - iKU), Celgene 

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Rafael Alfonso

Rafael Alfonso

Senior Director, Value Evidence and Outcomes, Scientific Lead - Americas, GSK

Read more

More information coming soon...

Riccardo Perfetti

Riccardo Perfetti

Former Senior Medical Officer, VP, Global Medical Affairs, Sanofi 

Read more

More information coming soon...

Rich Gliklich

Rich Gliklich

CEO, OM1

Read more

More information coming soon...

Rob Chipperfield

Rob Chipperfield

Executive Director, Client Engagement, Syneos Health

Read more
  • Over 12 years experience in developing and executing Value Evidence Generation Plans, starting in Phase I/II through Phase IV
    • Global HEOR, P&MA and Observational Research Therapeutic area expertise in Oncology, Diabetes, Cardiovascular Disease, Infectious Disease.
    • Spent 9 years at Cerner working with Pharmaceutical clients to design observational studies leveraging Cerner’s EHR system.
  • 23 years of experience in the pharmaceutical and medical device industries
    • Executive with pharmaceutical sales, consulting and marketing experience.
    • 12 years consulting in Pricing, Market Access, Health Economics, Health Outcomes and Late Phase Observational Research.
  • Studies focused on medication adherence, implementation of decision support in disease treatment and the impact of population health platforms in specific patient populations
    • Building, validating and commercializing data assets
  • Based in Phoenix, AZ (U.S.)
Rujul Desai

Rujul Desai

Of Counsel, Covington

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Scott Musial

Scott Musial

Head of Client Delivery, Aetion

Read more

More information coming soon...

Sean McElligott

Sean McElligott

Director, Market Access, Scientific and External Strategy, Janssen

Read more

More information coming soon...

Shontelle Dodson, Pharm.D

Shontelle Dodson, Pharm.D

Senior Vice President and Head of Medical Affairs, Astellas Americas

Read more

Shontelle Dodson has overall responsibility for the strategic direction of Astella’s Medical Affairs Americas organization, including continued medical support of in-line products, late-stage development compounds and ongoing business evolution across the region. Dodson has extensive clinical and research experience in the healthcare and pharmaceutical industries. After starting her career in direct patient care at the Department of Veterans Affairs, Dodson spent more than a decade at Pfizer in various Medical Affairs leadership roles spanning the urology and respiratory franchises. Following her work with Pfizer, Dodson then served as vice president of Medical Affairs at GTx, Inc., where she led a Phase 3 clinical development study of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer. She also incorporated key economic and health outcomes assessments to support product utilization and valuation.

Dodson has received multiple awards for leadership and innovation throughout her career, including the National Healthcare Business Women's Association Rising Star and the Astellas Vision Award. She earned a doctorate of pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tenn.

Susan Thornton

Susan Thornton

CEO, Cutaneous Lymphoma Foundation

Read more

More information coming soon...

Terrill Jordan

Terrill Jordan

President & CEO, Regional Cancer Care Associates

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Ulrich Neumann

Ulrich Neumann

Founder, Pharmvivo

Read more

Ulrich Neumann is the Founder and Managing Director of Pharmvivo Ventures, a NYC-based incubation platform for stakeholder exchanges in life sciences. He also serves as Sr. Director & Head of US Access, Commercial Strategy at Analytica Laser, a global research consultancy. In addition to US client advisory, his responsibilities include business and product development and customer-facing growth activities across the company's 20 target markets. Analytica is part of Certara, the global leader in model-informed drug development and regulatory submissions with 750+ professionals in 20+ countries. With a dual background in business management and public administration, Ulrich’s focuses on pricing and reimbursement, as well as activities on the US political, legislative and regulatory landscape to assess policy drivers, enablers and challenges to market access. His commercial experience lies in defining product strategy, value messaging and b2b brand development. The founder of several ventures, Ulrich has worked on go-to-market projects for 12+ year, leading multi-million $ P&Ls and cross-functional academic/commercial teams. He published two monographs in the policy field as well as various papers, reports and posters, holds an MSc from the London School of Economics, an MA from University of Southern California, Annenberg School and Marshall School of Business, and is nominated a Fellow of the Royal Society of Arts and Commerce since 2014.

Usman Iqbal MD, MPH, MBA

Usman Iqbal MD, MPH, MBA

VP, Medical Affairs, Acer Therapeutics

Read more

Dr. Usman Iqbal is a medical executive with a portfolio career entailing 15 years of diverse experience spanning Medical Affairs and end-to-end evidence and value development, across both large and small cap biopharmaceuticals. His experience spans a number of therapeutic areas including in Neuroscience, as Senior Medical Affairs Leader at AstraZeneca, and in Oncology, as former Head of Sanofi Oncology, Global Evidence & Value Development (GEVD). With positions of increasing responsibilities across both R&D and Medical Affairs in different organizations, Usman has led five product launches, built several integrated and transversal medical affairs platforms, and led the development and execution of integrated medical affairs strategy for broad portfolios including several orphan drugs. His area of expertise also includes Real World Evidence (RWE), and harnessing of big data science, advanced analytics & digital medicine to optimize medical affairs delivery and patient outcomes. Prior to working in the industry that also includes Amgen and Trevena, Usman was at the Boston University Health Outcomes Technology Group where he served as a senior research fellow at the Center for Assessment of Pharmaceutical Practices (CAPPs) and Veterans Affairs Pharmacy Benefit Management (VA-PBM). Usman serves as advisor to several academic and health care think tanks as an industry thought leader. He received his MD from Allama Iqbal Medical College, Lahore, Pakistan and MPH and MBA degrees from Boston University.

Zhen Su

Zhen Su

SVP & Chief Medical Officer, North America, EMD Serono

Read more

More information coming soon...

Christopher Boone

Christopher Boone

VP, Real World Data and Analytics, Pfizer

Read more

More information coming soon...

Khair ElZarrad

Khair ElZarrad

Deputy Director, Office of Medical Policy, FDA

Read more

More information coming soon...

Martin Marciniak

Martin Marciniak

Vice-President, U.S. Medical Affairs, Customer Engagement, Value, Evidence and Outcomes, GSK

Read more

More information coming soon...

John Bardi

John Bardi

VP, Public Affairs and Digital Medicine, Business Development, Otsuka

Read more

More information coming soon...

Zhen Su

Zhen Su

SVP & Chief Medical Officer, North America, EMD Serono

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Scott Musial

Scott Musial

Head of Client Delivery, Aetion

Read more

More information coming soon...

Anjan Chatterjee

Anjan Chatterjee

VP, Global Head, Real World Evidence - COE, Epidemiology and Big Data, Boehringer Ingelheim

Read more

More information coming soon...

Denise Globe

Denise Globe

VP, Head Global Real World Evidence Center of Excellence, Vertex Pharmaceuticals

Read more

More information coming soon...

Diana Stefani-Hunyady

Diana Stefani-Hunyady

Global Senior Director, IL-23 Medical Affairs Launch Lead, Eli Lilly

Read more

More information coming soon...

Patrick Loerch

Patrick Loerch

Senior Director, Data Sciences (Information, Knowledge Utilization - iKU), Celgene 

Read more

More information coming soon...

Bryan Hill

Bryan Hill

Medical Science Director, Mitsubishi 

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Eric Wittbrodt

Eric Wittbrodt

Director, Epidemiology, AstraZeneca 

Read more

More information coming soon...

April Naegeli

April Naegeli

Senior Research Scientist, Eli Lilly

Read more

More information coming soon...

Michael Ujhelyi

Michael Ujhelyi

Senior Medical Director, BTG

Read more

More information coming soon...

Rafael Alfonso

Rafael Alfonso

Senior Director, Value Evidence and Outcomes, Scientific Lead - Americas, GSK

Read more

More information coming soon...

Riccardo Perfetti

Riccardo Perfetti

Former Senior Medical Officer, VP, Global Medical Affairs, Sanofi 

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Rob Chipperfield

Rob Chipperfield

Executive Director, Client Engagement, Syneos Health

Read more
  • Over 12 years experience in developing and executing Value Evidence Generation Plans, starting in Phase I/II through Phase IV
    • Global HEOR, P&MA and Observational Research Therapeutic area expertise in Oncology, Diabetes, Cardiovascular Disease, Infectious Disease.
    • Spent 9 years at Cerner working with Pharmaceutical clients to design observational studies leveraging Cerner’s EHR system.
  • 23 years of experience in the pharmaceutical and medical device industries
    • Executive with pharmaceutical sales, consulting and marketing experience.
    • 12 years consulting in Pricing, Market Access, Health Economics, Health Outcomes and Late Phase Observational Research.
  • Studies focused on medication adherence, implementation of decision support in disease treatment and the impact of population health platforms in specific patient populations
    • Building, validating and commercializing data assets
  • Based in Phoenix, AZ (U.S.)
Anjan Chatterjee

Anjan Chatterjee

VP, Global Head, Real World Evidence - COE, Epidemiology and Big Data, Boehringer Ingelheim

Read more

More information coming soon...

Denise Globe

Denise Globe

VP, Head Global Real World Evidence Center of Excellence, Vertex Pharmaceuticals

Read more

More information coming soon...

Diana Stefani-Hunyady

Diana Stefani-Hunyady

Global Senior Director, IL-23 Medical Affairs Launch Lead, Eli Lilly

Read more

More information coming soon...

Patrick Loerch

Patrick Loerch

Senior Director, Data Sciences (Information, Knowledge Utilization - iKU), Celgene 

Read more

More information coming soon...

Bryan Hill

Bryan Hill

Medical Science Director, Mitsubishi 

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Eric Wittbrodt

Eric Wittbrodt

Director, Epidemiology, AstraZeneca 

Read more

More information coming soon...

April Naegeli

April Naegeli

Senior Research Scientist, Eli Lilly

Read more

More information coming soon...

Michael Ujhelyi

Michael Ujhelyi

Senior Medical Director, BTG

Read more

More information coming soon...

Rafael Alfonso

Rafael Alfonso

Senior Director, Value Evidence and Outcomes, Scientific Lead - Americas, GSK

Read more

More information coming soon...

Riccardo Perfetti

Riccardo Perfetti

Former Senior Medical Officer, VP, Global Medical Affairs, Sanofi 

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Rob Chipperfield

Rob Chipperfield

Executive Director, Client Engagement, Syneos Health

Read more
  • Over 12 years experience in developing and executing Value Evidence Generation Plans, starting in Phase I/II through Phase IV
    • Global HEOR, P&MA and Observational Research Therapeutic area expertise in Oncology, Diabetes, Cardiovascular Disease, Infectious Disease.
    • Spent 9 years at Cerner working with Pharmaceutical clients to design observational studies leveraging Cerner’s EHR system.
  • 23 years of experience in the pharmaceutical and medical device industries
    • Executive with pharmaceutical sales, consulting and marketing experience.
    • 12 years consulting in Pricing, Market Access, Health Economics, Health Outcomes and Late Phase Observational Research.
  • Studies focused on medication adherence, implementation of decision support in disease treatment and the impact of population health platforms in specific patient populations
    • Building, validating and commercializing data assets
  • Based in Phoenix, AZ (U.S.)
Amanda Bruno

Amanda Bruno

Head, Value, Evidence and Access, Oncology, GSK

Read more

More information coming soon...

Gergana Zlateva, Ph.D.

Gergana Zlateva, Ph.D.

Vice President, Payer Insights and Access, Pfizer Oncology

Read more

Gergana Zlateva is a Vice President, Oncology Global Lead for Payer Insights & Access (PI&A) in Global Health & Value. Gergana’ s team provides both region-specific and global support in the development and implementation of market access, pricing, reimbursement, and health technology assessment strategies for Pfizer’s oncology portfolio. Prior to this role, Gergana was the PI&A Cluster Lead for North America, and managed a team of colleagues supporting Pfizer’s portfolio and its 3 business: GIP, GEP, and VOC.  During her 13 year tenure with Pfizer, Gergana has held various positions of increasing responsibility covering health economics, outcomes research, and pricing and reimbursement activities across several therapy areas and different geographies. Gergana has led multiple cross-functional teams in preparation of pricing and reimbursement negotiations in developed markets and has presented on behalf of PFE to public and private payer organizations in the EU and US. Prior to joining Pfizer in 2003, Gergana worked for 5 years on public health, civil society, and business development programs with several United Nations agencies. Gergana holds a PhD in Economics from Fordham University, NY and a BA and MPA from Southern Illinois University, IL. Gergana’s CV includes more than 60 peer-reviewed manuscripts, as well as a number of poster and podium presentations.

Harry Vargo

Harry Vargo

Director, Value Based Contracting and Manufacturer Trade Relations, Aetna

Read more

More information coming soon...

Michael Thompson

Michael Thompson

President & CEO, National Alliance of Healthcare Purchaser Coalitions

Read more

More information coming soon...

Dan Leonard

Dan Leonard

President, National Pharmaceutical Council

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


David Hartenbaum

David Hartenbaum

Executive Director, Account Management, Merck

Read more

More information coming soon...

Matt Portch

Matt Portch

Vice President, Managed Markets, Sunovion Pharmaceutical

Read more

More information coming soon...

Shontelle Dodson, Pharm.D

Shontelle Dodson, Pharm.D

Senior Vice President and Head of Medical Affairs, Astellas Americas

Read more

Shontelle Dodson has overall responsibility for the strategic direction of Astella’s Medical Affairs Americas organization, including continued medical support of in-line products, late-stage development compounds and ongoing business evolution across the region. Dodson has extensive clinical and research experience in the healthcare and pharmaceutical industries. After starting her career in direct patient care at the Department of Veterans Affairs, Dodson spent more than a decade at Pfizer in various Medical Affairs leadership roles spanning the urology and respiratory franchises. Following her work with Pfizer, Dodson then served as vice president of Medical Affairs at GTx, Inc., where she led a Phase 3 clinical development study of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer. She also incorporated key economic and health outcomes assessments to support product utilization and valuation.

Dodson has received multiple awards for leadership and innovation throughout her career, including the National Healthcare Business Women's Association Rising Star and the Astellas Vision Award. She earned a doctorate of pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tenn.

Brad Patrick

Brad Patrick

Division Counsel, Abbvie

Read more

More information coming soon...

Terrill Jordan

Terrill Jordan

President & CEO, Regional Cancer Care Associates

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Michael Labson

Michael Labson

Partner, Covington

Read more

More information coming soon...

Rujul Desai

Rujul Desai

Of Counsel, Covington

Read more

More information coming soon...

Ulrich Neumann

Ulrich Neumann

Founder, Pharmvivo

Read more

Ulrich Neumann is the Founder and Managing Director of Pharmvivo Ventures, a NYC-based incubation platform for stakeholder exchanges in life sciences. He also serves as Sr. Director & Head of US Access, Commercial Strategy at Analytica Laser, a global research consultancy. In addition to US client advisory, his responsibilities include business and product development and customer-facing growth activities across the company's 20 target markets. Analytica is part of Certara, the global leader in model-informed drug development and regulatory submissions with 750+ professionals in 20+ countries. With a dual background in business management and public administration, Ulrich’s focuses on pricing and reimbursement, as well as activities on the US political, legislative and regulatory landscape to assess policy drivers, enablers and challenges to market access. His commercial experience lies in defining product strategy, value messaging and b2b brand development. The founder of several ventures, Ulrich has worked on go-to-market projects for 12+ year, leading multi-million $ P&Ls and cross-functional academic/commercial teams. He published two monographs in the policy field as well as various papers, reports and posters, holds an MSc from the London School of Economics, an MA from University of Southern California, Annenberg School and Marshall School of Business, and is nominated a Fellow of the Royal Society of Arts and Commerce since 2014.

Usman Iqbal MD, MPH, MBA

Usman Iqbal MD, MPH, MBA

VP, Medical Affairs, Acer Therapeutics

Read more

Dr. Usman Iqbal is a medical executive with a portfolio career entailing 15 years of diverse experience spanning Medical Affairs and end-to-end evidence and value development, across both large and small cap biopharmaceuticals. His experience spans a number of therapeutic areas including in Neuroscience, as Senior Medical Affairs Leader at AstraZeneca, and in Oncology, as former Head of Sanofi Oncology, Global Evidence & Value Development (GEVD). With positions of increasing responsibilities across both R&D and Medical Affairs in different organizations, Usman has led five product launches, built several integrated and transversal medical affairs platforms, and led the development and execution of integrated medical affairs strategy for broad portfolios including several orphan drugs. His area of expertise also includes Real World Evidence (RWE), and harnessing of big data science, advanced analytics & digital medicine to optimize medical affairs delivery and patient outcomes. Prior to working in the industry that also includes Amgen and Trevena, Usman was at the Boston University Health Outcomes Technology Group where he served as a senior research fellow at the Center for Assessment of Pharmaceutical Practices (CAPPs) and Veterans Affairs Pharmacy Benefit Management (VA-PBM). Usman serves as advisor to several academic and health care think tanks as an industry thought leader. He received his MD from Allama Iqbal Medical College, Lahore, Pakistan and MPH and MBA degrees from Boston University.

Denise Meade

Denise Meade

Director of Product Management, IBM Watson Health

Read more

More information coming soon...

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!


Don't miss out - register now

There are only a limited number of passes left - Secure your place to this sell out event!